Egetis Reports Tiratricol Study Results in 28 Patients With RTH-Beta

The retrospective international study reported mean FT4 down 37%, TSH down 43% and heart rate down 10 bpm. Tiratricol is not approved for RTH-beta; Egetis is preparing regulatory interactions.